USPTO Patents Application 10724746

PATENT

Attorney Docket No. 402883

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

In re Application of:
USAMI et al.

Application No. 10/724,746
Filed: December 2, 2003
For: RADOME

INFORMATION DISCLOSURE STATEMENT

Commissioner for Patents
U.S. Patent and Trademark Office
Customer Service Window, Mail Stop
Randolph Building
401 Dulany Street
Alexandria, V A 22314

Group Art Unit: 2821
Examiner: Unassigned

Pursuant to 37 CFR 1.97 and 1.98, the references listed on the enclosed Form PTO-1449
and/or Substitute Form PTO-1449 ("Form 1449") are submitted for consideration by the
Examiner in the examination of the above-identified patent application.

The full consideration of the references in their entirety by the Examiner is respectfully
requested and encouraged. Also, it is respectfully requested that the references be entered
into the record of the present application and that the Examiner place his or her initials in the
appropriate area on the enclosed Form 1449, thereby indicating the Examiner's consideration
of each of the references.

The submission of the references listed on the Form 1449 is for the purpose of providing a
complete record and is not a concession that the references listed thereon are prior art to the
invention claimed in the patent application. The right is expressly reserved to establish an
invention date earlier than the above-identified filing date in order to remove any reference
submitted herewith as prior art should it be deemed appropriate to do so.

Further, the submission of the references is not to be taken as a concession that any reference
represents art that is relevant or analogous to the claimed invention. Accordingly, the right to
argue that any reference is not properly within the scope of prior art relevant to an
examination of the claims in the above-identified application is also expressly reserved.

The Information Disclosure Statement is being filed:

13 within any one of the following time periods: (a) within three months of the filing
date of a national application other than a continued prosecution application under
37 CFR 1.53(d); (b) within three months of the date of entry of the national stage as

In re Appln. of USAMI et al.
Application No. 10/724,746

set forth in 37 CFR 1.491 of an international application; (c) before the mailing date
of a first Office Action on the merits; or (d) before the mailing of a first Office Action
after the filing of a request for continued examination under 37 CFR 1.1 14.

□ after (a), (b), (c) or (d) above, but before the mailing date of a final action under
37 CFR 1.113, a Notice of Allowance under 37 CFR 1.311, or an action that
otherwise closes prosecution in the application, and includes one of:

□ the Statement under 37 CFR 1.97(e) (see "Statement under 37 CFR 1.97(e)"
below).

or

□ the fee of $ 1 80 set forth in 37 CFR 1 . 1 7(p) (see "Fees" below).

□ after the mailing date of a final action under 37 CFR 1 . 1 1 3 or a Notice of Allowance
under 37 CFR 1 .3 1 1 , or an action that otherwise closes prosecution in the application,
and on or before payment of the issue fee, and includes the Statement under
37 CFR 1.97(e) (see "Statement under 37 CFR 1.97(e)" below), and the fee of $180 as
set forth in 37 CFR 1.1 7(p) (see "Fees" below).

□ after the mailing date of a Notice of Allowance under 37 CFR 1.311, and on or before
""^ payment of the issue fee, and within thirty days of receiving each item of information

contained in the Information Disclosure Statement, and includes the Statement under
37 CFR 1 .704(d) (see "Statement under 37 CFR 1 .704(d)" below), and the fee of
$ 1 80 as set forth in 37 CFR 1 . 1 7(p) (see "Fees" below).

NOTE: This is for original applications except applications for a design patent, filed on or after
May 29, 2000, wherein a paper containing only an Information Disclosure Statement in compliance
with 37 CFR 1.97 and 1.98 is being filed.

Copies of the References

□ Copies of the references listed on the enclosed Form 1449 are enclosed herewith.

£3 Copies of U.S. patents and patent applications that are listed on the accompanying
*"~* Form 1449 are not enclosed herewith. Copies of other references identified on the
accompanying Form 1449 are enclosed herewith.

£3 Attached to each reference not in the English language is a concise explanation of the
relevance pursuant to 37 CFR 1.98(a)(3). An English-language equivalent/patent, or
an English-language abstract, or an English-language version of the search report or
action by a foreign patent office in a counterpart foreign application indicating the
degree of relevance found by the foreign office is being submitted in lieu of a concise
explanation of the relevance pursuant to 37 CFR 1.98(a)(3).

^ A copy of the foreign search report is enclosed herewith.

□ The references listed on the enclosed Form 1449 were previously identified in the
parent application(s) of the present application, and copies of the references were
furnished at that time. Accordingly, additional copies of the references are not

2

In re Appln. of USAMI et al.
Application No. 10/724,746

submitted herewith, so as not to burden the file with duplicate copies of references.
The Examiner is respectfully requested to carefully review the references in
accordance with the requirements set out in the Manual of Patent Examining
Procedure. In accordance with 37 CFR 1.98(d), the details of the parent application(s)
relied upon for an earlier filing date under 35 USC 120 in which copies of the
references were previously furnished are set out below:

U.S. APPLICATIONS

Status (check one)

U.S. Applications

U.S. Filing Date

Patented

Pending

Abandoned

1.

2.

3.

Statement under 37 CFR 1.97(e)

13 The undersigned hereby states that each item of information contained in the
Information Disclosure Statement was first cited in any communication from a
foreign patent office in a counterpart foreign patent application not more than three
months prior to the filing of the Information Disclosure Statement.

□ The undersigned hereby states that no item of information contained in the
Information Disclosure Statement was cited in a communication from a foreign patent
office in a counterpart foreign patent application, and, to the knowledge of the
undersigned after making reasonable inquiry, no item of information contained in the
Information Disclosure Statement was known to any individual designated in
37 CFR 1.56(c) more than three months prior to the filing of the Information
Disclosure Statement.

Statement under 37 CFR 1.704(d)

□ The undersigned hereby states that each item of information contained in the
Information Disclosure Statement was cited in a communication from a foreign patent
office in a counterpart application and that this communication was not received by
any individual designated in 37 CFR 1.56(c) more than thirty days prior to the filing
of the Information Disclosure Statement.

Fees

^ No fee is owed by the applicant(s).

□ The IDS Fee of $180 under 37 CFR 1 . 1 7(p) is enclosed herewith.

Method of Payment of Fees

□ Attached is a check in the amount of $

□ Charge Deposit Account No. 12-1216 in the amount of $ . (A duplicate copy of
this communication is enclosed for that purpose.)

3

In re Appln. of USAMI et al.
Application No. 10/724,746

Authorization to Charge Additional Fees

^ If any additional fees are owed in connection with this communication, please charge
Deposit Account No. 12-1216. (A duplicate copy of this communication is enclosed
for that purpose.)

Instructions as to Overpayment

13 Credit Account No. 1 2- 1 2 1 6.
□ Refund

Respectfully submitted,

(202) 737-6770 (telephone)
(202) 737-6776 (facsimile)

IDS (Revised 1/14/05)

4

Please type a plus sign (+) inside this box — ^

Complete if Known

Substitute for form 1 449A/B/PTO r+*J3A\*

INFORMATION DISCLOSURE
STATEMENT BY APPLICANT

(Use as many sheets as necessary)

Application Number

10/724,740

Filing Date

December 2, 2003

First Named Inventor

USAMI et al.

Group Art Unit

2821 J

Examiner Name

Unassigned

Sheet | 1 I of 1

Attorney Docket Number

402883

U.S. PATENT DOCUMENTS

Examiner
! Initials

Doc. No.

U.S. Patent Document |

Name of Patentee or Applicant

Date of
Publication

Filing Date If
Appropriate

Application or
Patent Number

Kind
Code

B1

2,956,281

E.B. McMillan et al

10/11/1960

FOREIGN PATENT DOCUMENTS

Examiner
Initials

Doc. No.

Foreign Patent Document

Name of Patentee or Applicant

Date of
Publication

Trans

lation

Office

Application or
Patent Number

Kind
Code

Yes

No* +

B2

GB

633,943

John Betteley Birks

12/30/1949

j OTHER - NON PATENT LITERATURE DOCUMENTS

Examiner
Initials

Doc. No.

Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), tme oitne item
(book, magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number (s),
publisher, city and/or country where published.

Trans
Yes

lation
No* +

B3

B. R. RAO, "An optimization technique for the design of multi-frequency radomes
1990 Antennas and Propagation Symposium Digest. (05-07-1990), pages 1200-1203,

B4

C GIBSON et al., "Design of an 89 GHz radome", Radar Conference, 1998,
Radarcon 98, Proceedings of the 1998 IEEE Dallas TX, 11-14 May 1998, New York
NY, IEEE, US, (05/11/1998), pages 373-378

| Examiner J

Signature

J"" j Date Considered j ]

* a rnnrkp statement of relevance is beinq submitted in lieu of a translation. 37 UhK i.ytnajioj. ~

♦ ^TrSh^S^^K^. or an English-language abstract, or an English-language version of the search report or actior .fay . foregn
patent office in a counterpart foreign application indicating the degree of relevance found by the fore.gn office is being submitted in lieu of a concise
explanation of relevance under 37 CFR 1.98(a)(3).